Switching from originator biological agents to biosimilars: what is the evidence and what are the issues?

ABSTRACT:

SUBMITTER: Toussirot E 

PROVIDER: S-EPMC5604708 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature